Stay updated on Long-term Esketamine Study in Depression: Clinical Trial
Sign up to get notified when there's something new on the Long-term Esketamine Study in Depression: Clinical Trial page.

Latest updates to the Long-term Esketamine Study in Depression: Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check14 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.5%
- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedThe webpage has updated its version from v2.15.0 to v2.15.2 and has removed older dates from March 2025, replacing them with newer dates in April 2025.SummaryDifference0.2%
- Check57 days agoChange DetectedThe page has been updated to include new information about treatment-resistant depression, specifically mentioning the oral antidepressants Sertraline and Venlafaxine XR, as well as a new identifier for a study. The previous detailed description of the study's methodology and phases has been removed.SummaryDifference11%
- Check64 days agoChange DetectedThe page has been updated to reflect the latest version as v2.14.4, replacing the previous version v2.14.3. The estimated last update posted has been removed.SummaryDifference0.0%
- Check72 days agoChange DetectedThe web page has updated its version from v2.14.2 to v2.14.3 and has added new dates for March 2025 while removing previous dates from February 2025.SummaryDifference0.2%
Stay in the know with updates to Long-term Esketamine Study in Depression: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term Esketamine Study in Depression: Clinical Trial page.